Variant report

Variant	esv3431805
Chromosome Location	chr3:120626112-120628860
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CCNT2	chr3:120626977-120627177	K562	blood:	n/a	n/a
2	CEBPB	chr3:120627180-120627240	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD1	chr3:120627961-120627967	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD2	chr3:120627237-120627411	K562	blood:	n/a	n/a
5	CHD2	chr3:120626620-120626683	HepG2	liver:	n/a	n/a
6	CHD2	chr3:120626534-120627261	H1-hESC	embryonic stem cell:	n/a	chr3:120626931-120626941
7	CHD2	chr3:120627244-120627356	HepG2	liver:	n/a	n/a
8	CREB1	chr3:120626466-120627458	H1-hESC	embryonic stem cell:	n/a	n/a
9	CREB1	chr3:120626569-120627443	H1-hESC	embryonic stem cell:	n/a	n/a
10	CREB1	chr3:120626804-120627205	A549	lung:	n/a	n/a
11	CTBP2	chr3:120626470-120627895	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr3:120627740-120627890	WERI-Rb-1	eye:	n/a	n/a
13	CTCF	chr3:120627720-120627870	SK-N-SH_RA	brain:	n/a	n/a
14	CTCF	chr3:120627180-120627330	SK-N-SH_RA	brain:	n/a	n/a
15	E2F4	chr3:120628293-120628493	MCF10A-Er-Src	breast:	n/a	n/a
16	E2F6	chr3:120626439-120627417	H1-hESC	embryonic stem cell:	n/a	chr3:120626891-120626902 chr3:120626933-120626942 chr3:120627221-120627231 chr3:120626891-120626902 chr3:120627080-120627090 chr3:120626891-120626902
17	E2F6	chr3:120626471-120627765	H1-hESC	embryonic stem cell:	n/a	chr3:120626891-120626902 chr3:120626933-120626942 chr3:120627221-120627231 chr3:120626891-120626902 chr3:120627080-120627090 chr3:120626891-120626902
18	EGR1	chr3:120626809-120627186	K562	blood:	n/a	chr3:120626924-120626934 chr3:120626934-120626947 chr3:120626971-120626981
19	EGR1	chr3:120626843-120627185	K562	blood:	n/a	chr3:120626924-120626934 chr3:120626934-120626947 chr3:120626971-120626981
20	EGR1	chr3:120626763-120627264	MCF-7	breast:	n/a	chr3:120626924-120626934 chr3:120626934-120626947 chr3:120626971-120626981
21	ELF1	chr3:120626879-120627160	K562	blood:	n/a	n/a
22	FOS	chr3:120627938-120627961	MCF10A-Er-Src	breast:	n/a	n/a
23	FOXA1	chr3:120627796-120627980	T-47D	breast:	n/a	n/a
24	FOXA1	chr3:120626557-120627085	T-47D	breast:	n/a	n/a
25	GTF2F1	chr3:120626688-120627468	H1-hESC	embryonic stem cell:	n/a	n/a
26	HA-E2F1	chr3:120626513-120627604	MCF-7	breast:	n/a	chr3:120626891-120626902 chr3:120626933-120626942 chr3:120627221-120627231 chr3:120626891-120626902 chr3:120627080-120627090 chr3:120626891-120626902
27	HCFC1	chr3:120627020-120627022	K562	blood:	n/a	n/a
28	HDAC2	chr3:120626832-120627378	MCF-7	breast:	n/a	chr3:120627062-120627081
29	HDAC2	chr3:120626972-120627192	H1-hESC	embryonic stem cell:	n/a	chr3:120627062-120627081
30	HMGN3	chr3:120626866-120627265	K562	blood:	n/a	n/a
31	IRF1	chr3:120626740-120627181	K562	blood:	n/a	chr3:120626929-120626943 chr3:120627026-120627040
32	JUND	chr3:120626462-120627376	H1-hESC	embryonic stem cell:	n/a	n/a
33	JUND	chr3:120627047-120627166	K562	blood:	n/a	n/a
34	MAX	chr3:120626450-120626832	H1-hESC	embryonic stem cell:	n/a	chr3:120626801-120626811
35	MAX	chr3:120626498-120627826	H1-hESC	embryonic stem cell:	n/a	chr3:120626801-120626811
36	MAX	chr3:120626461-120627713	H1-hESC	embryonic stem cell:	n/a	chr3:120626801-120626811
37	MAX	chr3:120626883-120627270	K562	blood:	n/a	n/a
38	MAX	chr3:120626821-120627587	A549	lung:	n/a	n/a
39	MAX	chr3:120626873-120627347	MCF-7	breast:	n/a	n/a
40	MAX	chr3:120626871-120627513	A549	lung:	n/a	n/a
41	MAX	chr3:120627283-120627459	HepG2	liver:	n/a	n/a
42	MAX	chr3:120626837-120627474	ECC-1	luminal epithelium:	n/a	n/a
43	MAX	chr3:120626947-120627129	K562	blood:	n/a	n/a
44	MAX	chr3:120626955-120627155	K562	blood:	n/a	n/a
45	MAX	chr3:120626803-120627716	ECC-1	luminal epithelium:	n/a	n/a
46	MAZ	chr3:120626845-120627173	HepG2	liver:	n/a	n/a
47	MAZ	chr3:120626708-120627468	K562	blood:	n/a	chr3:120626801-120626811
48	MXI1	chr3:120626555-120627334	H1-hESC	embryonic stem cell:	n/a	n/a
49	MXI1	chr3:120626257-120628925	SK-N-SH	brain:	n/a	n/a
50	MXI1	chr3:120626756-120627378	IMR90	lung:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:120627406-120627456	AG10803	skin:	n/a
2	chr3:120627406-120627456	AG10803	skin:	n/a
3	chr3:120628291-120628341	HMEC	breast:	n/a
4	chr3:120628544-120628594	HCM	heart:	n/a
5	chr3:120626881-120626931	RPTEC	kidney:	n/a
6	chr3:120627170-120627220	HRPEpiC	eye:	n/a
7	chr3:120626667-120626717	PANC-1	pancreas:	n/a
8	chr3:120627170-120627220	IMR90	lung:	fetal
9	chr3:120627088-120627138	Jurkat	blood:	n/a
10	chr3:120626899-120626949	RPTEC	kidney:	n/a
11	chr3:120627170-120627220	A549	lung:	n/a
12	chr3:120626653-120626703	AoSMC	blood vessel:	n/a
13	chr3:120628291-120628341	GM19239	blood:	n/a
14	chr3:120628544-120628594	PANC-1	pancreas:	n/a
15	chr3:120626899-120626949	NT2-D1	testis:	n/a
16	chr3:120626911-120626961	Hepatocyte	liver:	n/a
17	chr3:120627170-120627220	HCT-116	colon:	n/a
18	chr3:120626911-120626961	MCF10A-Er-Src	breast:	n/a
19	chr3:120626135-120626185	SK-N-SH	brain:	n/a
20	chr3:120626135-120626185	HPAEpiC	pulmonary alveolar:	n/a
21	chr3:120626653-120626703	LNCaP	prostate:	n/a
22	chr3:120627085-120627135	U87	brain:	n/a
23	chr3:120626911-120626961	HUVEC	blood vessel:	n/a
24	chr3:120626881-120626931	Caco-2	colon:	n/a
25	chr3:120627406-120627456	ProgFib	skin:	n/a
26	chr3:120627406-120627456	HUVEC	blood vessel:	n/a
27	chr3:120627085-120627135	NB4	blood:	n/a
28	chr3:120626881-120626931	BJ	skin:	n/a
29	chr3:120626135-120626185	HAEpiC	amniotic membrane:	n/a
30	chr3:120628291-120628341	GM06990	blood:	n/a
31	chr3:120627170-120627220	NH-A	brain:	n/a
32	chr3:120626881-120626931	ECC-1	luminal epithelium:	n/a
33	chr3:120628291-120628341	AoSMC	blood vessel:	n/a
34	chr3:120626911-120626961	HAEpiC	amniotic membrane:	n/a
35	chr3:120626881-120626931	T-47D	breast:	n/a
36	chr3:120628544-120628594	NH-A	brain:	n/a
37	chr3:120628291-120628341	HCM	heart:	n/a
38	chr3:120628544-120628594	HRCEpiC	kidney:	n/a
39	chr3:120627406-120627456	LNCaP	prostate:	n/a
40	chr3:120626881-120626931	NHDF-neo	bronchial:	n/a
41	chr3:120628544-120628594	SKMC	muscle:	n/a
42	chr3:120628291-120628341	IMR90	lung:	fetal
43	chr3:120626653-120626703	CMK	blood:	n/a
44	chr3:120626881-120626931	K562	blood:	n/a
45	chr3:120626653-120626703	HRE	kidney:	n/a
46	chr3:120627406-120627456	HEK293	kidney:	embryo
47	chr3:120626899-120626949	BJ	skin:	n/a
48	chr3:120627085-120627135	SK-N-MC	brain:	n/a
49	chr3:120627085-120627135	SK-N-SH	brain:	n/a
50	chr3:120627085-120627135	HCM	heart:	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RABL3-2	chr3:120626876-120626902	XLOC_003227

Variant related genes	Relation type
STXBP5L	TF binding region
STXBP5L	CpG island

Extended variants
information (count: 96 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:96 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs375931269	chr3:120626135-120626136	Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
2	rs577309715	chr3:120626136-120626137	Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs543117660	chr3:120626156-120626157	Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
4	rs561987774	chr3:120626183-120626184	Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs73858205	chr3:120626207-120626208	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs573598892	chr3:120626209-120626210	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs73858206	chr3:120626267-120626268	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs10662871	chr3:120626300-120626301	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs72418448	chr3:120626301-120626302	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs564924856	chr3:120626304-120626305	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs147090489	chr3:120626339-120626340	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs528424926	chr3:120626346-120626347	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs470931	chr3:120626429-120626430	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs9826042	chr3:120626484-120626485	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs184091655	chr3:120626496-120626497	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs551113642	chr3:120626518-120626519	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs561324234	chr3:120626526-120626527	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs567628749	chr3:120626537-120626538	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs147707178	chr3:120626578-120626579	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs530088323	chr3:120626637-120626638	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs539886833	chr3:120626644-120626645	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs9826303	chr3:120626661-120626662	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs72964782	chr3:120626703-120626704	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs558685806	chr3:120626734-120626735	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs371389168	chr3:120626738-120626739	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs570058417	chr3:120626740-120626741	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs569130749	chr3:120626746-120626747	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs375671344	chr3:120626760-120626761	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs556623177	chr3:120626801-120626802	Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs573683500	chr3:120626850-120626851	Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs74819094	chr3:120626881-120626882	Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
32	rs552737159	chr3:120626999-120627000	Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs368223189	chr3:120627008-120627009	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs189223924	chr3:120627011-120627012	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs565041987	chr3:120627048-120627049	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs369135636	chr3:120627078-120627079	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs146476187	chr3:120627085-120627086	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs544450726	chr3:120627086-120627087	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs561410129	chr3:120627121-120627122	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs375369992	chr3:120627132-120627133	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs530180395	chr3:120627134-120627135	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs367927484	chr3:120627175-120627176	Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs566761294	chr3:120627292-120627293	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs532811601	chr3:120627304-120627305	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs559695220	chr3:120627367-120627368	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs532679097	chr3:120627400-120627401	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs112372546	chr3:120627437-120627438	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs181839522	chr3:120627476-120627477	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs566246825	chr3:120627577-120627578	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs538029135	chr3:120627676-120627677	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Prostate cancer	21965145	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
microdeletion syndrome	22180640	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	16608533	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Developmental delay	22180640	CNVD
Multiple myeloma	17550852	CNVD
Basal cell lymphoma	21115979	CNVD
Ovarian cancer	22174824	CNVD
lymphocytic leukemia	21291569	CNVD
small cell lung cancer	20016488	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Autism	22241247	CNVD

Chromatin state (count:361 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:120626000-120626200	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
2	chr3:120626000-120627800	Active TSS	iPS-20b Cell Line	embryonic stem cell
3	chr3:120626200-120626400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr3:120626200-120626400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
5	chr3:120626200-120626600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
6	chr3:120626200-120626600	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
7	chr3:120626200-120628000	Active TSS	HUES48 Cell Line	embryonic stem cell
8	chr3:120626200-120628000	Active TSS	HUES64 Cell Line	embryonic stem cell
9	chr3:120626200-120628600	Active TSS	iPS-18 Cell Line	embryonic stem cell
10	chr3:120626200-120628800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
11	chr3:120626200-120629000	Active TSS	ES-I3 Cell Line	embryonic stem cell
12	chr3:120626200-120630200	Active TSS	Pancreatic Islets	Pancreatic Islet
13	chr3:120626400-120626600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr3:120626400-120626600	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr3:120626400-120626600	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
16	chr3:120626400-120626600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
17	chr3:120626400-120626600	Enhancers	Brain Hippocampus Middle	brain
18	chr3:120626400-120626600	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
19	chr3:120626400-120626600	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
20	chr3:120626400-120626600	Active TSS	Fetal Adrenal Gland	Adrenal Gland
21	chr3:120626400-120626600	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
22	chr3:120626400-120626800	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr3:120626400-120626800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr3:120626400-120626800	Enhancers	Pancreas	Pancrea
25	chr3:120626400-120627200	Active TSS	Fetal Brain Female	brain
26	chr3:120626400-120627800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr3:120626400-120627800	Active TSS	Fetal Brain Male	brain
28	chr3:120626400-120627800	Bivalent/Poised TSS	Fetal Intestine Large	intestine
29	chr3:120626400-120628000	Bivalent/Poised TSS	Brain Germinal Matrix	brain
30	chr3:120626400-120628000	Active TSS	Fetal Kidney	kidney
31	chr3:120626400-120628400	Active TSS	Brain Cingulate Gyrus	brain
32	chr3:120626400-120628400	Active TSS	Rectal Smooth Muscle	rectum
33	chr3:120626400-120628600	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr3:120626400-120628600	Active TSS	iPS-15b Cell Line	embryonic stem cell
35	chr3:120626400-120628600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr3:120626400-120628600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr3:120626400-120628600	Active TSS	Brain Anterior Caudate	brain
38	chr3:120626400-120628800	Active TSS	H1 Cell Line	embryonic stem cell
39	chr3:120626400-120628800	Active TSS	H9 Cell Line	embryonic stem cell
40	chr3:120626400-120628800	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
41	chr3:120626400-120629200	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
42	chr3:120626400-120630400	Active TSS	Brain Angular Gyrus	brain
43	chr3:120626400-120630400	Active TSS	Brain Inferior Temporal Lobe	brain
44	chr3:120626600-120626800	Bivalent/Poised TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
45	chr3:120626600-120626800	Bivalent/Poised TSS	Primary B cells from cord blood	blood
46	chr3:120626600-120626800	Enhancers	Primary hematopoietic stem cells short term culture	blood
47	chr3:120626600-120626800	Bivalent/Poised TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr3:120626600-120626800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
49	chr3:120626600-120626800	Enhancers	Adipose Nuclei	Adipose
50	chr3:120626600-120626800	Flanking Bivalent TSS/Enh	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links